|Articles|June 8, 2017
Exom Group starts Caravaggio Study, Cloud & Mobile Clinical Trial
Advertisement
Exom Group launched the Caravaggio Study, a Cloud & Mobile Clinical Trial, that will randomize around 1, 200 patients from 160 clinical sites spanning Europe, Israel, and the U.S.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research
2
When AI Learns to Speak Every Language: An eCOA Migration Study
3
Using Digital Tools to Enhance Patient-Centric Trials
4
Gilead’s ARTISTRY-2 Trial Shows Bictegravir Lenacapavir Combo Matches Biktarvy in Virologically Suppressed Adults With HIV
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
